[The immunosuppressive treatment of pure erythroblastopenia, using cyclophosphamide and antilymphocyte globulins].
D000368:Aged; D000741:Anemia, Aplastic / Q000188:drug therapy* / Q000276:immunology; D000906:Antibodies / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001772:Blood Cell Count; D001856:Bone Marrow Examination; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007501:Iron / Q000097:blood; D008297:Male; D008875:Middle Aged; D012514:Sarcoma, Kaposi / Q000150:complications; D013945:Thymoma / Q000150:complications / Q000188:drug therapy
D000906:Antibodies; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D007501:Iron
Il trattamento immunosoppressivo della eritroblastopenia pura per mezzo di ciclofosfamide e di globuline antilinfocitarie